Barclays Raises CME Group (NASDAQ:CME) Price Target to $225.00

CME Group (NASDAQ:CME – Free Report) had its price objective increased by Barclays from $222.00 to $225.00 in a report released on Thursday, Benzinga reports. Barclays currently has an equal weight rating on the financial services provider’s stock. Other research analysts also recently issued reports about the company. Morgan Stanley lifted their price target on […]

Related Keywords

Bryant Durkin ,Derek Sammann ,Cme Group ,Capital Wealth Planning ,Goldman Sachs Group ,Norges Bank ,Group Stock Performance ,Morgan Stanley ,Group Inc ,Group Increases Dividend ,Barclays ,Group Daily ,Pricet Rowe Associates Inc ,Free Report ,Rosenblatt Securities ,Get Free Report ,Director Bryan ,Wealth Planning ,World Investors ,Pricet Rowe Associates ,Nasdaq Cme ,Cme ,Finance ,12572q10 ,Boost Price Target ,Barclays Plc ,